NASDAQ:NAOVNanoVibronix Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NanoVibronix Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.07 +0.07 (+3.50 %) (As of 05/25/2020 04:00 PM ET) Add Compare Share Today's Range$2.02Now: $2.07▼$2.2950-Day Range$1.76MA: $2.04▼$2.3552-Week Range$1.42Now: $2.07▼$4.20Volume8,577 shsAverage Volume10,386 shsMarket Capitalization$9.22 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products in the United States, Israel, Europe, India, and internationally through distributor agreements. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for NanoVibronix. Previous Next 2.0 Community Rank Outperform VotesNanoVibronix has received 71 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNanoVibronix has received 106 “underperform” votes. (Add your “underperform” vote.)Community SentimentNanoVibronix has received 59.89% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about NanoVibronix and other stocks. Vote “Outperform” if you believe NAOV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NAOV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNanoVibronix does not currently pay a dividend.Dividend GrowthNanoVibronix does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NanoVibronix insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 16.90% of the stock of NanoVibronix is held by insiders.Percentage Held by InstitutionsOnly 13.49% of the stock of NanoVibronix is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for NanoVibronix are expected to grow in the coming year, from ($0.81) to ($0.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NanoVibronix is -2.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NanoVibronix is -2.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNanoVibronix has a P/B Ratio of 6.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.53 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NAOV Previous Symbol CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone914-233-3004Debt Debt-to-Equity RatioN/A Current Ratio4.49 Quick Ratio4.20Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$530,000.00 Price / Sales17.40 Cash FlowN/A Price / Cash FlowN/A Book Value$0.30 per share Price / Book6.90Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-5,790,000.00 Net Margins-1,093.21% Return on Equity-460.57% Return on Assets-256.66%Miscellaneous Employees10 Outstanding Shares4,454,000Market Cap$9.22 million Next Earnings Date5/25/2020 (Estimated) OptionableNot Optionable NASDAQ:NAOV Rates by TradingView Receive NAOV News and Ratings via Email Sign-up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. NanoVibronix (NASDAQ:NAOV) Frequently Asked Questions How has NanoVibronix's stock been impacted by COVID-19 (Coronavirus)? NanoVibronix's stock was trading at $2.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NAOV shares have decreased by 24.7% and is now trading at $2.07. View which stocks have been most impacted by Coronavirus. When is NanoVibronix's next earnings date? NanoVibronix is scheduled to release its next quarterly earnings announcement on Monday, May 25th 2020. View our earnings forecast for NanoVibronix. How were NanoVibronix's earnings last quarter? NanoVibronix Inc (NASDAQ:NAOV) announced its quarterly earnings results on Wednesday, November, 14th. The company reported ($0.21) earnings per share for the quarter. The firm earned $0.05 million during the quarter. NanoVibronix had a negative return on equity of 460.57% and a negative net margin of 1,093.21%. View NanoVibronix's earnings history. Has NanoVibronix been receiving favorable news coverage? News stories about NAOV stock have been trending somewhat positive on Monday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. NanoVibronix earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutNanoVibronix. Are investors shorting NanoVibronix? NanoVibronix saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 6,900 shares, a decline of 16.9% from the April 15th total of 8,300 shares. Based on an average trading volume of 9,100 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.2% of the shares of the stock are sold short. View NanoVibronix's Current Options Chain. Who are some of NanoVibronix's key competitors? Some companies that are related to NanoVibronix include Histogenics (HSGX), Ocugen (OCGN), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), Bionik Laboratories (BNKL) and Avitar (AVTI). View all competitors. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some companies that other NanoVibronix investors own include Canopy Growth (CGC), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX), Digital Ally (DGLY), Onconova Therapeutics (ONTX), Sierra Oncology (SRRA), Actinium Pharmaceuticals (ATNM), Biocept (BIOC), Inovio Pharmaceuticals (INO) and Inpixon (INPX). Who are NanoVibronix's key executives? NanoVibronix's management team includes the following people: Mr. Brian M. Murphy, CEO & Director (Age 62)Dr. William Stern, Pres (Age 77)Mr. Stephen R. Brown CPA, Chief Financial Officer (Age 63)Dr. Harold Jacob, Chief Medical Officer & Director (Age 65)Mr. Amir Rippel, VP of Marketing What is NanoVibronix's stock symbol? NanoVibronix trades on the NASDAQ under the ticker symbol "NAOV." How do I buy shares of NanoVibronix? Shares of NAOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is NanoVibronix's stock price today? One share of NAOV stock can currently be purchased for approximately $2.07. How big of a company is NanoVibronix? NanoVibronix has a market capitalization of $9.22 million and generates $530,000.00 in revenue each year. NanoVibronix employs 10 workers across the globe. What is NanoVibronix's official website? The official website for NanoVibronix is www.nanovibronix.com. How can I contact NanoVibronix? NanoVibronix's mailing address is 525 Executive Blvd, Elmsford NY, 10523. The company can be reached via phone at 914-233-3004 or via email at [email protected] This page was last updated on 5/25/2020 by MarketBeat.com Staff
